* Terclara® cutaneous solution 98mg/ml is an over-the-counter medicine with terbinafine for the treatment of mild to moderate nail fungus on fingernails and toenails. From 18 years. Terclara® can be used if you have previously been diagnosed by a doctor. Consult a doctor or pharmacist if you are pregnant, breastfeeding, have diabetes, immune disease or peripheral vascular disease. If there is no improvement after 6 months for fingernails and 9-12 months for toenails, contact a doctor. Read the package insert carefully before use. Allderma AB, terclara.se
From Swedish innovation to global patient impact
Moberg Pharma is a Swedish specialty pharmaceutical company in the commercial stage, active in dermatology and focused on developing innovative, proven substances into new, proprietary medicines. Our product MOB-015 is a new topical treatment for onychomycosis, approved in 13 EU countries. We develop solutions that combine strong clinical efficacy, ease of use, and clear patient benefits aiming to improve treatment outcomes for millions of patients worldwide.
Interview with CEO Anna Ljung
Anna Ljung, CEO
Our business model means lower development risk and greater opportunities to reach the market quickly than traditional drug development.
